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Abstract 
Background: Diabetic retinopathy is one of the micro vascular complications of diabetes mellitus. To date there are 
no studies that show the magnitude of diabetic retinopathy in the pediatric population of Ethiopia with only very few 
in Africa. The purpose of this study was to determine the prevalence of diabetic retinopathy in children and adoles-
cents at a tertiary center in Ethiopia.
Methods: This cross-sectional hospital based descriptive study included children aged between 9 and 17 years 
attending the endocrine follow-up clinic of Tikur Anbesa Specialized Hospital. A structured questionnaire was used for 
evaluating sociodemographic data and information pertinent to diabetes. The prevalence of diabetic retinopathy was 
determined by fundus photography of each eye.
Results: A total of 86 patients were examined with a mean age of 13.7 (SD = 1.8) years. At onset of diabetes, 95.6 % 
of children presented with diabetic ketoacidosis(DKA); 22 children (25.6 %) had at least two episodes of DKA, and 45 
children (52.3 %) had poor glycemic control. Background retinopathy was present in four children (4.7 %) with a mean 
age of 14.25 (SD = 1.89) years and two of them also had maculopathy.
Conclusion: Although there are some methodological limitations, this study highlights the difficulties of achieving 
good glycemic control and the early occurrence of diabetic retinopathy in Ethiopian diabetic children.
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Background
Diabetic retinopathy is one of the micro vascular com-
plications of diabetes mellitus that results from damage 
to retinal capillaries and venules. It is the most common 
micro vascular disease seen in children and adolescents 
with type 1 diabetes and the most common cause of 
acquired blindness in young adults in United States [1, 2]. 
Prolonged duration of diabetes, poor glycemic control, 
hypertension, hyperlipidemia and genetic predisposition 
are risk factors for the development of diabetic retinopa-
thy [3–6]. Family history of complications of diabetes and 
higher body mass index are other risk factors [7].
The results of prevalence studies of diabetic retinopathy 
are variable. A few studies have reported mild diabetic 
retinopathy in children with duration of disease as short 
as 1–2 years but in most studies the duration is 3 or more 
years, with typical durations of 8–10 years before devel-
opment of retinopathy [8–11]. The prevalence of dia-
betic retinopathy ranged from 0–28 % in various studies 
[12–16]. Long-term metabolic control has a significant 
influence on the prevalence of retinopathy: in one study, 
it was found that patients with a median HbA1c ≥7.5 % 
had developed diabetic retinopathy on average after 
15.5  years compared with 18.3  years in patients with 
lower HbA1c values [8].
There are several screening guidelines for pediatric 
diabetic retinopathy that are more or less similar rec-
ommending annual screening after 3–5  years of initial 
diagnosis of diabetes [17–19]. The International Society 
for Pediatric and Adolescent Diabetes (ISPAD) suggests 
that annual screening for retinopathy to be conducted in 
patients aged 11 years after diabetes of 2 years’ duration 
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To date there are no studies that show the magnitude 
of diabetic retinopathy in the pediatric population of 
Ethiopia with only very few in Africa. This has limited 
the attention to adopting any of the recognized screening 
tools to date. The current study assessed the prevalence 
and details of children with diabetic retinopathy strictly 
following the recommendations of ISPAD.
Methods
Design and setting
The cross-sectional descriptive study was conducted at 
Addis Ababa University, Collage of Health Sciencesand 
Pediatrics Endocrine Clinic in collaboration with the dia-
betic retinopathy screening program in the adult diabetes 
clinic of Tikur Anbessa Specialized Hospital that is found 
in the capital of Ethiopia, Addis Ababa.The pediatrics endo-
crine clinic is functional once weekly to evaluate patients 
on management and follow up. There are 212 type-1 dia-
betic patients having follow-up in the clinic, and on average 
25–30 patients are evaluated on each follow-up day.
The ISPAD 2009 recommendation for retinopathy 
screening was followed to select the study subjects as it 
allows for the screening of children as young as 9 years 
with diabetic duration of 5 years or more [6]. All diabetic 
patients age 9  years and above with diabetic duration 
of 5  years and more, and diabetic patients whose age is 
greater than or equal to 11 years with diabetic duration 
of more than 2 years were selected. All of them were less 
than 18 years of age.
Data collection
The selected patients who agreed to participate in the 
study were contacted by phone and were appointed for 
retinopathy screening. After receiving informed con-
sent, the patients’ charts were reviewed, a standard ques-
tionnaire was administered and the patients, parents or 
guardians were interviewed and information pertinent to 
their diabetes (duration of diabetes, associated complica-
tions and co-morbidity) was collected.
Patients were asked if they had symptoms of neu-
ropathy (numbness, pain and burning sensation of the 
hands and feet, and paresthesia) and the responses 
were recorded on the questionnaire. Patients, parents 
or guardians were asked if the study subjects had had 
screening laboratory tests for renal complication of dia-
betes (nephropathy). Those who had had the tests were 
asked if they had developed the renal complication. The 
responses were recorded on the questionnaire.
The vision of each eye was tested separately using Snellen 
distant vision chart at 6 m; uncorrected visual acuity of 6/6 
or superior to 6/6 in both eyes was taken as normal [19].
Height and weight were measured without shoes. Body 
mass index (BMI) (weight in kg, divided by square of 
height in meters) was calculated, and BMI of <5th per-
centile andBMI of 95th percentile and above for age was 
taken as underweight and over-weight, respectively [20].
The results of HbA1c measurements of patients were 
documented, for those who had no HbA1c measurement, 
the average of the fasting blood sugar measurements 
of the last 1  month was taken to estimate the glycemic 
control. HbA1c results more than or equal to 10 %, and 
average fasting blood sugar level of more than 150 mg/dl 
for patients 11 years old and below, more than130 mg/dl 
for those between 12 years and 15 years of age, and more 
than 120 mg/dl for those between 16 and 18 years were 
taken as indicator of poor glycemic control [21].
Retinopathy was assessed using fundal photography of 
both eyes after dilating the pupils using 1 drop of tropi-
camide eye drops. The fundal photographs were taken 
with a Topcon Fundus Camera (TRC.NW 100; made in 
England) by nurses trained in digital diabetic retinopathy 
screening. Two fields of each eye (macular view and disc 
view) were photographed and the severity of retinopa-
thy was determined by the grading of the most seriously 
affected eye. For the purpose of this study diabetic retin-
opathy was classified as follows [21]:
1. Background or nonproliferative retinopathy: cotton-
wool spots, intra retinal hemorrhages, exudates, and 
micro vascular abnormalities (including micro aneu-
rysms, occluded vessels, and dilated or tortuous ves-
sels) primarily in the macula and posterior retina.
2. Proliferative retinopathy: presence of neovasculariza-
tion arising from the disc and/or retinal vessels and 
the consequences of this neovascularization, includ-
ing pre retinal and vitreous hemorrhage, subsequent 
fibrosis, and traction retinal detachment.
3. Maculopathy: The presence of exudates in the mac-
ula (region of the retina with-in a circular area of two 
disc diameters centered on the fovea) was considered 
as maculopathy as it is difficult to diagnose retinal 
thickening and edema from non-stereo color photo-
graphs.
Statistical analysis
The data were entered in the Statistical Package for Social 
Sciences (SPSS inc.) software (version 20) data base. Data 
were presented as frequency (percentage), mean (stand-
ard deviation), and median (range). Chi square test or 
Fisher’s exact test was used to ascertain the association 
between categorical variables.Statistically significant 
association was taken for P values of <0.05.
Ethical consideration
The study was conducted after obtaining ethical clear-
ance from the Ethical committee of the Department of 
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Pediatrics and Child Health, and the Institutional Review 
Board of Addis Ababa University, Collage of Health 
Sciences.
Written informed consent was obtained from the par-
ents of participants for undergoing the study and for pub-
lication of the study results. Parental consent was also 
obtained to publish the clinical information contained in 
Table 2.
Results
Among a total of 212 children who had follow up at Tikur 
Anbessa Specialized Hospital, 90 (45 %) of them full filled 
the criteria based on the recommendations of ISPAD and 
four of the selected didn’t appear for screening. The mean 
age of the participants was 13.7 (SD  =  1.8) years with 
95  % CI, 13.3–14.1. Females accounted for 54.7  %. The 
duration of follow up since the first diagnosis of diabetes 
ranged from 2–5  years in 35 (40.7  %); 6–10  years in 36 
(41.9 %); and above 10 years in 15 (17.4 %) children. The 
age at diagnosis of diabetes was before 12 years for 95.3 % 
of the study subjects (Table 1). Most (83.7 %) of the dia-
betic children having follow-up at the diabetic clinic were 
from the city of Addis Ababa, and the remaining came 
from towns and villages surrounding the city.
Among the 86 children included in the study, only 
55(63.9  %) children had HbA1cmeasurements. Thirty 
nine (70.9 %) of them had two HbA1c measurements and 
the remaining 16 children had only one HbA1c through-
out their follow up. Among the children who had HbA1c 
measurement, 33 (60.0 %) had high (≥10 %) HbA1c levels 
(average HbA1C = 11.2 %). For the remaining 31 patients 
who did not have HbA1c measurement, the average of 
the fasting blood sugar of the last 1 month from patient 
logs was taken as a measure of glycemic control. Eight-
een (58.0  %) had high average 1  month fasting blood 
sugar levels (mean fasting blood glucose = 272.4 mg/dl, 
SD =  12.5). Overall, based on the few HbA1c measure-
ments and the average fasting blood sugar levels they 
had, it was apparent that 45 (52.3  %) patients had poor 
glycemic control that lasted for at least a few months.
The majority (95.6  %) of the study subjects presented 
with diabetic ketoacidosis (DKA) at onset of diabetes. 
Most children (74.4 %) had only one episode of DKA dur-
ing their follow up; whereas 17 (19.8 %), 4 (4.7 %), and 1 
(1.2) had twice, three and five times, respectively. Most 
of the study subjects measured their blood sugar only in 
the mornings except for occasional twice daily measure-
ments but they did not test their urinary glucose.
Previous retinopathy screening during follow up had 
been done for only 21 (24.4  %) patients and two of the 
screened patients had had background retinopathy. Sixty 
eight (79.1  %) patients had normal visual acuity, while 
18 (20.9 %) patients had abnormal visual acuity. Patients 
with abnormal visual acuity were referred to an oph-
thalmologist for evaluation. Only 11 patients (12.8  %) 
reported that they had had nephropathy screening and 




First presented with DKA
 Yes 83 96.5
 No 3 3.5
Diabetic Duration
 2–5 years 35 40.7
 6–10 years 36 41.9
 > 10 years 15 17.4
Frequency of DKA since diagnosis
 1 64 74.4
 2 17 19.8
 3 and above 5 5.8
Diabetic nephropathy
 Yes 0 0
 No 11 12.8
 Never been screened 75 87.2
Neuropathy
 Yes 4 4.7
 No 84 95.3
Previous retinopathy screening
 Yes 21 24.4
 No 65 75.6
Body mass index
 Under weight 24 27.9
 Normal 62 72.1
 Over weight 0 0
Height for age
 Normal 69 80.5
 Stunted 17 19.5
Hypertension
 Yes 1 1.16
 No 85 98.84
Visual acuity
 Normal 68 79.1
 Abnormal 18 20.9
Glycemic control
 Good 41 47.7
 Poor 45 52.3
Retinopathy
 Yes 4 4.7
 No 82 95.3
Stage of retinopathy
 Background/nonproliferative 4 100
 Proliferative 0 0
 Maculopathy 2 50
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all had been told that they had no nephropathy. Four 
(4.7  %) patients had symptoms of neuropathy and they 
were linked to the pediatric neurology clinic for further 
evaluation.
Four of the 86 included children (4.7  %) fulfilled the 
diagnostic criteria for background diabetic retinopa-
thy. Two of these patients also had maculopathy (back-
ground retinopathy involving the macula). The mean 
age of the children with diabetic retinopathy was 14.25 
(SD =  1.89) years. The youngest child with retinopathy 
was 13  year old with diabetic duration of 10  years. No 
patient was found to have diabetic eye disease beyond 
background retinopathy in this study. All of them were 
female. The patients with maculopathy had reduced vis-
ual acuity but we did not know whether or not the mac-
ulopathy is responsible for their impaired vision. They 
were referred to an ophthalmologist for evaluation like 
the other patients with reduced visual acuity. All of the 
patients with retinopathy had high average HbA1c level 
(mean HbA1c = 12.4 %, SD = 0.88) and all presented with 
DKA at initial diagnosis. There was only one case with 
symptoms suggestive of peripheral neuropathy (Case 4; 
Table 2). All patients were taking a mixture of regular and 
Neutral Protamine Hagedorn (NPH) insulin subcutane-
ously (one third of the total daily dose being regular insu-
lin and two third NPH). At the time of the study, two of 
the patients with retinopathy were taking 1 unit/kg insu-
lin and the remaining two were taking 1.2 unit/kg insu-
lin. Two third of the total dose was given in the morning 
and one third in the evening. Detailed description of the 
cases is presented in Table 2.
Discussion
The current study found that 90 (42.4 %) children having 
follow up at the diabetic clinic of Tikur Anbessa Special-
ized Hospital fulfilled the ISPAD criteria for undergoing 
diabetic retinopathy screening. All the screened patients 
were adolescents. The majority of the included children 
had a diabetic duration of 6–10 years.
As observed in this study our diabetic children did not 
have regular HbA1c measurements making evaluation of 
long term metabolic control difficult. Among the study 
subjects, only 55 (63.9 %) had HbA1cmeasurements, the 
highest frequency being two measurements for their 
entire diabetic duration. Although we did not know their 
overall glycemic control throughout their diabetic dura-
tion, the few HbA1c values and the 1 month average fast-
ing blood glucose measurements reflected the clearly 
apparent poor glycemic control in more than half of the 
study subjects for at least a few months.
Despite the recommendations of ISPAD, little is known 
about the true impact of complications of diabetes, 
including diabetic retinopathy in the Ethiopian pediatric 
population. Screening for all of the microvarscular com-
plications of diabetes was not routinely done indicating a 
suboptimal proactive follow up of these children. To our 
best knowledge this effort constitutes the first attempt to 
estimate the prevalence of diabetic retinopathy among 
pediatric diabetics in the country although the study sub-
jects are not representative of the overall diabetic chil-
dren in the country as they came from only the capital 
city and its surrounding areas.
The prevalence of pediatric diabetic retinopathy in 
pediatric diabetic patients having follow-up in Tikur 
Anbesa Specialized Hospital was found to be 4.7 %. Two 
patients also had associated maculopathy that could 
threaten their vision even though the stage of their retin-
opathy is background retinopathy. The reduced visual 
acuity in these two patients could be due to the macu-
lopathy although further evaluation is needed to know 
the exact cause of their low visual acuity as it can also be 
affected by other factors like refractive error. The four 
patients with retinopathy and all those study subjects 
with reduced visual acuity were referred to an ophthal-
mologist for further evaluation, intervention and follow 
up.
Although we found out that all patients with retinop-
athy had high HbA1c measurements, we could not con-
clude that these patients had long standing poor glycemic 
control as one or two HbA1c values will be insufficient to 
describe the long term metabolic control. It is well known 
that the development of retinopathy takes years and an 
Table 2 Description of cases with diabetic retinopathy
Yr years, Dx diagnosis, NEUR neuropathy, HbA1c hemoglobin A1 C, BMI body mass index, NEP nephropathy, DKAf diabetic ketoacidosis frequency, F female, N normal, 
V/A visual acuity, UNK unknown, U unit, kg kilogram




BMI NEUR NEP V/A Retinopathy 
stage
Maculopathy DKAf Insulin dose 
(u/kg)
1 14 F 2 12.5 N None No 6/6 Backgroud No 1 1.2
2 13 F 3 11.2 N None UNK 6/12 Backgroud Yes 3 1
3 17 F 6 13.3 N None UNK 6/6 Backgroud No 2 1.2
4 13 F 3 12.7 N Yes UNK 6/12 Backgroud Yes 2 1
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HbA1c measurement reflects the average blood glucose 
concentration from the preceding 2–3  months. Simi-
larly, although it is well known from many other studies 
that prolonged poor glycemic control is associated with 
increased risk of development of retinopathy, we could 
not show this in our study due to the small number of our 
study subjects.
The finding that no patient was found to have prolif-
erative retinopathy in our study is comparable to the 
findings elsewhere [22]. The prevalence of pediatric 
diabetic retinopathy in the current study is lower than 
that reported in other populations such as the study in 
Tanzania (22.2  %) [15], and Australia (8  % in children 
<11 years; 28 % in children >11 years) [16]. However, it 
is higher than those seen in other studies: France (4.5 %) 
[14] and Iceland (0 %) [12]. The substantial heterogeneity 
in reported prevalence of retinopathy may partly be real, 
for example due to genetic differences of different popu-
lations, but may also be due to differences in study meth-
odology and population sample.The finding that there is 
poor glycemic control in the majority of our study sub-
jects is similar to the findings in other African settings 
[15, 23].
The current study revealed that few patients had previ-
ous retinopathy screening despite the availability of the 
service through the Ethiopian Diabetic Association. The 
possible reasons for this, while they should be studied 
systematically, could be shortage of resources, low aware-
ness of the practicing professionals in the center or fail-
ure to follow guidelines for follow up of such patients. 
This practice should be improved to detect the occur-
rence of diabetic retinopathy before patients develop 
vision threatening complication. Among the four patients 
with retinopathy, two had had retinopathy screening 
1  year before the current evaluation that showed back-
ground retinopathy, and there was no progression of the 
stage of retinopathy after 1 year.
One of the major limitations of the current study is 
the inability to evaluate the long term glycemic control 
of the study subjects. Factors associated with the risk of 
developing diabetic retinopathy could not also be studied 
because of the small number of study subjects. The cause 
of the reduced visual acuity was not known in the patients 
with maculopathy as we could not get the ophthalmolo-
gist’s evaluation in time due to the long waiting list. Even 
though the center where the study was conducted is the 
largest national referral center for such cases, and many 
children from around the country come for follow up, 
the study still cannot be considered as representative of 
the pediatric diabetic population in the country. We also 
could not provide definition to the other complications of 
diabetes since we used chart review to obtain the data.
In conclusion, diabetic retinopathy, though uncom-
mon, is a possible early complication in diabetic children 
in this setting. Hence, systematic screening should be in 
place for all micro vascular complications of diabetes.
The results clearly show that major efforts are needed to 
improve quality of care in children with type 1 diabetes 
in Ethiopia. We recommend that children with diabetes 
should be followed for development of any complications 
using standard guidelines like ISPAD 2014. The patients 
with retinopathy should also be followed prospectively 
to evaluate the progression of their retinopathy. We also 
recommend more studies to assess the magnitude and 
the determinants of developing diabetic retinopathy, and 
the state of glycemic control and its determinants in the 
country using a large number of representative study 
subjects.
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